Cardiovascular Systems (CSII) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'
February 9, 2023 11:12 AM EST(Updated - February 9, 2023 11:27 AM EST)
UPDATE: Updated to include analyst comments.
Abbott (NYSE: ABT) announced today that the medical device company has entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (NASDAQ: CSII). Under terms of the agreement, CSII stockholders will receive $20 per common share at a total expected equity value of approximately $890... More
